|
|
Previous Article | Table of Contents | Next Article 
Analysis of optimal conditions for retroviral-mediated transduction of
primitive human hematopoietic cells
JA Nolta, EM Smogorzewska and DB Kohn
Childrens Hospital Los Angeles, University of Southern California School of
Medicine, Department of Pediatrics 90027, USA.
We sought to define optimal conditions for retroviral-mediated transduction
of long-lived human hematopoietic progenitors from bone marrow and
peripheral blood. CD34+ cells were transduced by the LN and G2 retroviral
vectors in the presence or absence of stromal support and with or without
cytokine addition. After transduction, a portion of the cells was plated in
methylcellulose colony-forming assay, with or without G418, to assess the
extent of gene transfer into committed progenitors. The remaining cells
from each experiment were transplanted into immunodeficient mice to allow
analysis of transduction of long- lived progenitors. Human colony-forming
cells contained within the murine bone marrow were analyzed after
engraftment periods of 2 to 11 months. Cells were plated in a
human-specific colony-forming assay with and without G418 to assess the
extent of transduction of primitive progenitors. Individual human colonies
were also analyzed by polymerase chain reaction for the presence of
provirus. Bone marrow progenitors were efficiently transduced only when
stroma was present, whereas mobilized peripheral blood progenitors were
effectively transduced in the presence of either stroma or cytokines.
Inclusion of the cytokines interleukin-3, interleukin-6, and stem cell
factor did not further augment the extent of gene transfer in the presence
of a stromal support layer. Additionally, human CD34+ progenitors from bone
marrow or mobilized peripheral blood that had been transduced for 3 days in
the absence of stroma failed to produce sustained, long-term engraftment of
bnx mice. Mice transplanted with the same pools of human progenitors that
had been transduced in the presence of stroma for 3 days had significant
levels of human cell engraftment at the same timepoints, 7 to 11 months
after transplantation. Our data show loss of long-lived human progenitors
during 3-day in vitro transduction periods in the absence of stromal
support. Therefore, the presence of bone marrow stroma has dual benefits in
that it increases gene transfer efficiency and is essential for survival of
long-lived human hematopoietic progenitors.
Volume 86,
Issue 1,
pp. 101-110,
07/01/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Dao and J. A. Nolta
Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow
Blood,
March 15, 2007;
109(6):
2373 - 2379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Dao, J. Arevalo, and J. A. Nolta
Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution
Blood,
January 1, 2003;
101(1):
112 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Chute, A. A. Saini, D. J. Chute, M. R. Wells, W. B. Clark, D. M. Harlan, J. Park, M. K. Stull, C. Civin, and T. A. Davis
Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow
Blood,
December 15, 2002;
100(13):
4433 - 4439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Grove, C. Lutzko, J. Priller, O. Henegariu, N. D. Theise, D. B. Kohn, and D. S. Krause
Marrow-Derived Cells as Vehicles for Delivery of Gene Therapy to Pulmonary Epithelium
Am. J. Respir. Cell Mol. Biol.,
December 1, 2002;
27(6):
645 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bennaceur-Griscelli, C. Pondarre, V. Schiavon, W. Vainchenker, and L. Coulombel
Stromal cells retard the differentiation of CD34+CD38low/neg human primitive progenitors exposed to cytokines independent of their mitotic history
Blood,
January 15, 2001;
97(2):
435 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Tsark, M. A. Dao, X. Wang, K. Weinberg, and J. A. Nolta
IL-7 Enhances the Responsiveness of Human T Cells That Develop in the Bone Marrow of Athymic Mice
J. Immunol.,
January 1, 2001;
166(1):
170 - 181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. MacKenzie, N. R. Hackett, R. G. Crystal, and M. A. S. Moore
Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term culture
Blood,
July 1, 2000;
96(1):
100 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Schiedlmeier, K. Kuhlcke, H. G. Eckert, C. Baum, W. J. Zeller, and S. Fruehauf
Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice
Blood,
February 15, 2000;
95(4):
1237 - 1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rosenzweig, T.J. MacVittie, D. Harper, D. Hempel, R.L. Glickman, R.P. Johnson, A.M. Farese, N. Whiting-Theobald, G.F. Linton, G. Yamasaki, et al.
Efficient and Durable Gene Marking of Hematopoietic Progenitor Cells in Nonhuman Primates After Nonablative Conditioning
Blood,
October 1, 1999;
94(7):
2271 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Goerner, B. Bruno, P. A. McSweeney, G. Buron, R. Storb, and H.-P. Kiem
The Use of Granulocyte Colony-Stimulating Factor During Retroviral Transduction on Fibronectin Fragment CH-296 Enhances Gene Transfer Into Hematopoietic Repopulating Cells in Dogs
Blood,
October 1, 1999;
94(7):
2287 - 2292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Piacibello, F. Sanavio, A. Severino, A. Dane, L. Gammaitoni, F. Fagioli, E. Perissinotto, G. Cavalloni, O. Kollet, T. Lapidot, et al.
Engraftment in Nonobese Diabetic Severe Combined Immunodeficient Mice of Human CD34+ Cord Blood Cells After Ex Vivo Expansion: Evidence for the Amplification and Self-Renewal of Repopulating Stem Cells
Blood,
June 1, 1999;
93(11):
3736 - 3749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Punzel, S.D. Wissink, J.S. Miller, K.A. Moore, I.R. Lemischka, and C.M. Verfaillie
The Myeloid-Lymphoid Initiating Cell (ML-IC) Assay Assesses the Fate of Multipotent Human Progenitors In Vitro
Blood,
June 1, 1999;
93(11):
3750 - 3756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. I. Rebel, M. Tanaka, J.-S. Lee, S. Hartnett, M. Pulsipher, D. G. Nathan, R. C. Mulligan, and C. A. Sieff
One-Day Ex Vivo Culture Allows Effective Gene Transfer Into Human Nonobese Diabetic/Severe Combined Immune-Deficient Repopulating Cells Using High-Titer Vesicular Stomatitis Virus G Protein Pseudotyped Retrovirus
Blood,
April 1, 1999;
93(7):
2217 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.A. Dao, K. Hashino, I. Kato, and J.A. Nolta
Adhesion to Fibronectin Maintains Regenerative Capacity During Ex Vivo Culture and Transduction of Human Hematopoietic Stem and Progenitor Cells
Blood,
December 15, 1998;
92(12):
4612 - 4621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Dao, N. Taylor, and J. A. Nolta
Reduction in levels of the cyclin-dependent kinase inhibitor p27kip-1 coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells
PNAS,
October 27, 1998;
95(22):
13006 - 13011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-P. Kiem, R. G. Andrews, J. Morris, L. Peterson, S. Heyward, J. M. Allen, J. E.J. Rasko, J. Potter, and A. D. Miller
Improved Gene Transfer Into Baboon Marrow Repopulating Cells Using Recombinant Human Fibronectin Fragment CH-296 in Combination With Interleukin-6, Stem Cell Factor, FLT-3 Ligand, and Megakaryocyte Growth and Development Factor
Blood,
September 15, 1998;
92(6):
1878 - 1886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Veena, C. M. Traycoff, D. A. Williams, J. McMahel, S. Rice, K. Cornetta, and E. F. Srour
Delayed Targeting of Cytokine-Nonresponsive Human Bone Marrow CD34+ Cells With Retrovirus-Mediated Gene Transfer Enhances Transduction Efficiency and Long-Term Expression of Transduced Genes
Blood,
May 15, 1998;
91(10):
3693 - 3701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Conneally, C.J. Eaves, and R.K. Humphries
Efficient Retroviral-Mediated Gene Transfer to Human Cord Blood Stem Cells With In Vivo Repopulating Potential
Blood,
May 1, 1998;
91(9):
3487 - 3493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood,
February 15, 1998;
91(4):
1101 - 1134.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Luens, M. A. Travis, B. P. Chen, B. L. Hill, R. Scollay, and L. J. Murray
Thrombopoietin, kit Ligand, and flk2/flt3 Ligand Together Induce Increased Numbers of Primitive Hematopoietic Progenitors From Human CD34+Thy-1+Lin- Cells With Preserved Ability to Engraft SCID-hu Bone
Blood,
February 15, 1998;
91(4):
1206 - 1215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rosenzweig, D. F. Marks, D. Hempel, M. Heusch, G. Kraus, F. Wong-Staal, and R. P. Johnson
Intracellular Immunization of Rhesus CD34+ Hematopoietic Progenitor Cells With a Hairpin Ribozyme Protects T Cells and Macrophages From Simian Immunodeficiency Virus Infection
Blood,
December 15, 1997;
90(12):
4822 - 4831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Humeau, C. Chabannon, M. T. Firpo, P. Mannoni, C. Bagnis, M.-G. Roncarolo, and R. Namikawa
Successful Reconstitution of Human Hematopoiesis in the SCID-hu Mouse by Genetically Modified, Highly Enriched Progenitors Isolated From Fetal Liver
Blood,
November 1, 1997;
90(9):
3496 - 3506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. I. Gan, B. Murdoch, A. Larochelle, and J. E. Dick
Differential Maintenance of Primitive Human SCID-Repopulating Cells, Clonogenic Progenitors, and Long-Term Culture-Initiating Cells After Incubation on Human Bone Marrow Stromal Cells
Blood,
July 15, 1997;
90(2):
641 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bagnis and P. Mannoni
Stem Cell-Based Gene Therapy
Oncologist,
June 1, 1997;
2(3):
196 - 202.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.V.B. Emmons, S. Doren, J. Zujewski, M. Cottler-Fox, C.S. Carter, K. Hines, J.A. O'Shaughnessy, S.F. Leitman, J.J. Greenblatt, K. Cowan, et al.
Retroviral Gene Transduction of Adult Peripheral Blood or Marrow-Derived CD34+ Cells for Six Hours Without Growth Factors or on Autologous Stroma Does Not Improve Marking Efficiency Assessed In Vivo
Blood,
June 1, 1997;
89(11):
4040 - 4046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bauer, P. Valdez, K. Kearns, I. Bahner, S. F. Wen, J. A. Zaia, and D. B. Kohn
Inhibition of Human Immunodeficiency Virus-1 (HIV-1) Replication After Transduction of Granulocyte Colony-Stimulating Factor-Mobilized CD34+ Cells From HIV-1-Infected Donors Using Retroviral Vectors Containing Anti-HIV-1 Genes
Blood,
April 1, 1997;
89(7):
2259 - 2267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Dao, C. H. Hannum, D. B. Kohn, and J. A. Nolta
FLT3 Ligand Preserves the Ability of Human CD34+ Progenitors to Sustain Long-Term Hematopoiesis in Immune-Deficient Mice After Ex Vivo Retroviral-Mediated Transduction
Blood,
January 15, 1997;
89(2):
446 - 456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-S. Lu, S.-J. Wang, and R. Auerbach
In vitro and in vivo differentiation into B cells, T cells, and myeloid cells of primitive yolk sac hematopoietic precursor cells expanded >100-fold by coculture with a clonal yolk sac endothelial cell line
PNAS,
December 10, 1996;
93(25):
14782 - 14787.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|